IP Library Granted Patent US 8,323,897
Granted Patent B2
US 8,323,897 · App. 10/723,520 · Granted Dec 4, 2012

Multiplex amplification of polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,323,897
App. No.
10/723,520
Granted
Dec 4, 2012
Kind
B2
Abstract

The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.

Claims (19)

1. A method for analyzing a sample or plurality of samples for the presence of one or more polynucleotide sequences of interest, comprising:

(i) amplifying at least one of said polynucleotides of interest in the presence of:

(a) a plurality of different amplification primer pairs suitable for amplifying said polynucleotide sequences of interest; and

(b) a plurality of oligonucleotide probes, wherein each of said plurality of oligonucleotide probes is complementary to a region of a different polynucleotide sequence of interest amplified by said plurality of primer pairs and comprises a label suitable for monitoring amplification as a function of time; and

(ii) amplifying the products of said step (i) by dividing said products of step (i) into a plurality of aliquots and performing real-time polymerase chain reaction (PCR) on at least one of said aliquots in the presence of:

(a) at least one of said primer pairs used in step (i); and

(b) at least one of said oligonucleotide probes used in step (i) wherein said oligonucleotide probe in step (ii) is complementary to a region of a polynucleotide sequence of interest amplified by said primer pair in step (ii),

wherein said step (i) amplifying is carried out for less than 40 cycles.

2. The method of claim 1 in which the amplification of step (i) is further carried out in the presence of a reverse transcriptase such that the polymerase chain reaction is reverse-transcription polymerase chain reaction and wherein the one or more polynucleotide sequences is obtained from mRNA derived from the sample.

3. The method of claim 1 in which the one or more polynucleotide sequences comprise a cDNA library.

4. The method of claim 1 in which the polymerase chain reaction of step (i) is carried out for a number of cycles such that the amplification remains in the linear range.

5. The method of claim 1 in which the amplification in step (i) is achieved with a thermostable DNA polymerase.

6. The method of claim 1 in which the label is a fluorophore.

7. The method of claim 1 in which said plurality of oligonucleotide probes is selected from the group consisting of 5′-exonuclease probes, stem-loop beacon probes and stemless beacon probes.

8. The method of claim 1 in which an observed efficiency of amplification is greater than 70%.

9. The method of claim 1 in which an observed efficiency of amplification is greater than 90%.

10. The method of claim 1 in which the amplification is carried out in the presence of uracil N-glycosylase.

11. The method of claim 1 in which the amplifying of step (i) comprises fewer than fifteen PCR cycles.

12. The method of claim 1 , wherein said less than 40 cycles is a number of cycles suitable to keep said amplification reaction within the exponential or linear phase.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038002/0175 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2004
From: ANDERSEN, MARK R.; RUFF, DAVID W.
To: APPLERA CORPORATION
Reel/Frame 015670/0710 →